Veradermics is a dermatologist-founded, late clinical-stage biopharmaceutical company focused on turning everyday dermatology and aesthetics problems into clear, proven care. The company is developing novel therapeutics for common skin and hair conditions, with a lead candidate, VDPHL01, potentially the first non-hormonal oral treatment for hair regrowth in women and men. Headquartered in New Haven, Connecticut, they pursue clinical development and translational research to address underserved dermatology needs.